Patient Engagement Suite

  1. IRT And eClinical Technology Considerations For Cell And Gene Therapy 8/20/2021

    Don't try to fit cell and gene therapy studies – or any kind of study – into pre-defined functionality. The Cenduit IRT and Quantum Interactive™ agile design platforms and reporting tools support clients’ most complex requirements.

  2. Navigating The Use Of Controlled Substances In Clinical Trials Using IRT 8/20/2021

    Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.

  3. Removing The Barriers To eConsent Adoption 8/5/2021

    eConsent technology has existed for nearly 20 years in various iterations. Read how sponsors have taken a cautious approach to using eConsent, piloting it on individual studies but refraining from incorporating it across all pipelines in clinical operations.

  4. IQVIA Complete Consent 6/17/2021

    Engage with this friendly, feature-rich technology platform that's built with powerful, scalable, operational infrastructure that sponsors need to make global implementations successful.

  5. Tips For Overcoming Today's Drug Supply Challenges Through Technology 6/16/2021

    In this webinar, explore how to manage a supply chain through IRT with self service tools and actionable insights as well as best practices for supply forecasting and overstock management.

  6. Trials And Tribulations Of Electronic Patient Consent: Removing Barriers To eConsent Adoption 6/3/2021

    After a decade of dabbling with eConsent, how can sponsors and technology providers meet the demand to bring clinical trials directly to the patient at a global scale? In this webinar, you’ll learn strategies to overcome the persistent challenges in eConsent adoption and gain the benefits promised from successful decentralized trials with remote capabilities for patients and sites.

  7. The Case For Patient Diversity In Clinical Trials 2/25/2021

    Uncover how a global pharmaceutical company met the FDA's challenge to increase patient diversity with a multi-tiered approach combining key tactics and technology.

  8. Pharma Sponsor Enlists Cenduit IRT To Rescue A Multi-Country, Multi-Site Oncology Study 2/24/2021

    After go-live, the sponsor learned its study did not fit the existing IRT solution, affecting data quality, timelines, and drug supply shipments. The legacy system’s medication management algorithm could not support the required flexibility in the supply chain. The trial included an adaptive cohort design. Read how Cenduit delivered a high-quality study achieved through innovation, close client collaboration, and expert project management.

  9. Flexible IRT Platform Solution For National Lung Cancer Trial 2/24/2021

    Trial design for a medicine trial to investigate treatment for non-small cell lung cancer presents unique challenges. These include the need for an IRT platform that can support the rapid incorporation of amendments and account for multiple or potential arms requiring different lists of material types and dosages that could be prescribed to patients and supplied to sites. Cenduit’s highly-configurable, flexible technology platform was the solution.

  10. Navigating Patient Consent Scenarios In COVID-19 Trials 5/20/2020

    Many people have questions on the topic of remote consent in a hospital setting, particularly when the patient is quite ill and requires a legally acceptable representative (LAR) to consent on his or her behalf. This article shares insights gained through real-world implementations of remote consent.